ClinicalTrials.gg
CompletedNCT07172633Updated Oct 22, 2026

Effects of Dementia Scenario-Based Simulation Teaching Combined With Virtual Technology Among Nursing Students

An interventional study of scenario-based simulation teaching with virtual technology and traditional dementia case discussions in Dementia Simulation-based Teaching, sponsored by Huei-Chuan Sung. Completed at 1 site in Taiwan. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-22.

Sponsored by Huei-Chuan Sung · Not applicable, Interventional, and Other

How we know

Updated Oct 22, 2026Now CompletedStart date moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
41
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 105 studies in Dementia with a site in Taiwan — 23 open to participants now, 28 under way, 1 of them phase 3. Dementia · Taiwan.

Enrollment
64th of 84
41 · median 100
Started
2025
with 14 others
No phase
66 of 105
12 open now
Registered
88th of 105
by date

Among the 105 studies in Dementia with a site in Taiwan, this one is the 64th largest by enrollment of the 84 interventional ones that give a count, is one of 15 that started in 2025, is one of 66 with no phase, and was the 88th registered.

Dementia

2,377 studies on the registry are indexed under Dementia; 572 are open to participants now.

Browse Dementia studies →

Open to participants now

23 of the 105 studies in Dementia with a site in Taiwan are open now. Recruiting first, the newest first:

18 more — sign in →

All 23 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 382 Dementia studies recruiting now, 242 (63%) set no upper age limit and 25 (7%) stop at 75 or younger; 15 take children under 18; 163 take healthy volunteers.

This study: 18 Years to 40 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 105 studies in Dementia with a site in Taiwan, or all of them as a file.
02

Study summary

This study aims to evaluate the effects of scenario-based simulation teaching with virtual technology on dementia knowledge, empathy, communication, and assessment skills among nursing students.

Read the detailed description

This two-group randomised controlled trial aims to evaluate the effects of scenario-based simulation teaching with virtual technology on dementia knowledge, empathy, communication, and assessment skills among nursing students.

The interventional group will receive the 5-week scenario-based simulation teaching with a virtual coach in addition to regular dementia care lectures.

The control group will receive the 5-week traditional dementia case discussions in addition to regular dementia care lectures.

Both groups will be assessed for their dementia knowledge, empathy, communication, and assessment skills at baseline, week 12, and week 18.

03

Conditions studied

  • Dementia Simulation-based Teaching

Browse trials for

Keywords

  • Simulation-based teaching
  • virtual technology
  • dementia
  • nursing student
04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • college nursing students with ages ranging from 18 to 40 years,
  • Taiwanese nationality,
  • provide to participate in the study.

Exclusion criteria

Exclusion Criteria:

  • college nursing students who do not meet the inclusion criteria
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
41 participants (actual)

Study arms

  • Experimental
    Scenario-based simulation teaching with virtual technology

    5-week scenario-based simulation teaching with a virtual coach intervention in addition to regular dementia care lectures

    Other: scenario-based simulation teaching with virtual technology

  • Active comparator
    traditional dementia case discussions

    5-week traditional dementia case discussions in addition to regular dementia care lectures

    Other: traditional dementia case discussions

Interventions

  • Otherscenario-based simulation teaching with virtual technology

    5-week scenario-based simulation teaching with a virtual coach acting as an older adult with dementia in addition to regular dementia care lectures

  • Othertraditional dementia case discussions

    5-week traditional dementia case discussions in addition to regular dementia care lectures

06

What researchers measure

Primary outcomes

  1. Dementia Knowledge Assessment Scale

    Dementia Knowledge

    Time frame: baseline, week 12, week 18

  2. Jefferson Scale of Empathy

    empathy

    Time frame: baseine, week 12, week 18

  3. Nursing Students' Communication Behavior with Dementia Patients Scale

    Communication behavior with dementia patients

    Time frame: baseine, week 12, week 18

  4. Health Professionals Communication Skills Scale

    communication skills

    Time frame: baseline, week 12, week 18

Secondary outcomes

  1. Dementia Assessment Practice Rubrics

    assessment skills for people with dementia

    Time frame: baseline, week 12, week 18

07

Study locations

1 site
  • Tzu Chi University
    Hualien City, Hualien 970, Taiwan
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2025 to primary completion in Jul 2026, 11 months.

Of 862 non-industry interventional studies with no phase under Dementia, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's 11 months is below that.

Counting every sponsor, half of 908 studies reached it within 25 months; a quarter within 11 and three quarters within 43.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 22, 2026: start Sep 2025 → Aug 2025 and primary completion Jan 2026 → Jul 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 8, 2025
First posted
Sep 15, 2025
StartActual
Aug 1, 2025was Sep 2025
Primary completionActual
Jul 31, 2026was Jan 2026
CompletionActual
Jul 31, 2026
Last update
Oct 22, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Oct 22, 2026
Start date
Sep 10, 2025→Aug 1, 2025
Oct 22, 2026
Primary completion
Jan 31, 2026→Jul 31, 2026 (actual)
Oct 22, 2026
Enrollment
50 (estimated)→41 (actual)
Oct 22, 2026
Show all 1 update
  1. Oct 22, 2026
    Recruiting→Completed
    Start date Sep 10, 2025→Aug 1, 2025
    Primary completion Jan 31, 2026→Jul 31, 2026 (now actual)
    Enrollment 50 (estimated)→41 (actual)
    + 4 other changes: verification date, design details, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07172633
Lead sponsor
Huei-Chuan Sung
Responsible party
Huei-Chuan Sung (Associate professor, Tzu Chi University) — Sponsor-investigator
First posted
Sep 15, 2025
Start date
Aug 1, 2025
Primary completion
Jul 31, 2026
Completion
Jul 31, 2026
Last update
Oct 22, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion